Cleopatra Hospital Company’s (CHC) (CLHO.CA) Board of Directors (BoD) met on 17 July 2016 and approved  EGP360mn capital increase that will be distributed over 40mn shares at EGP9/share (EGP0.5 par value plus EGP8.5 share premium) and through a closed subscription to Care Healthcare Ltd., CHC’s major shareholder that will own c80% of the company post the capital increase. The BoD approved amending the company’s Articles of Association to reflect the rise in  paid-in capital from EGP80mn to EGP100mn. The capital increase will be financed from the proceeds of the recent secondary offering, and the decision follows the AGM’S approval that was held on 6 April 2016 and as mentioned in CHC’S prospectus published in May 2016. (Company disclosure)   Cleopatra Hospital Company (CHC): EGP9.25 as of 18 July 2016, Rating: Buy, FV: EGP11.70 per share, MCap: USD167mn, CLHO EY / CLHO.CA